Anika Therapeutics | ANIK - Ebit





Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 6.62B 1.51B 2026-03
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Sanofi EUR 1.94B 239M 2026-03
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.1B 867M 2026-03
Surmodics USD 58K 380K 2025-06
Veracyte USD 19.08M 5.55M 2026-03
Xencor USD -77.86M 24.23M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03